# Scribe Manufacturing, Inc. – FDA Inspection, Nov 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/scribe-manufacturing-inc/531632b5-70cf-4dfa-a7a9-7113b0a86a98
Source feed: FDA_Inspections

> FDA inspection 1226061 of Scribe Manufacturing, Inc., November 30, 2023. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226061
- Company Name: Scribe Manufacturing, Inc.
- Inspection Date: 2023-11-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 995398 - 2016-11-17](https://www.keypedia.com/records/fda_inspections/scribe-manufacturing-inc/4cab5877-0289-4d0e-9f2b-5f51315b01c6)
- [FDA Inspection 765520 - 2012-01-26](https://www.keypedia.com/records/fda_inspections/scribe-manufacturing-inc/0b317271-2fd1-4a9a-a294-1caf3ed81bb5)
- [FDA Inspection 634063 - 2009-11-23](https://www.keypedia.com/records/fda_inspections/scribe-manufacturing-inc/bc50d73b-8ff1-4274-8efa-72544c6dc560)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/soyinka-s-eneng/a7f69c63-1beb-4c59-9ccd-6e35c49a10c5)

Company: https://www.keypedia.com/companies/scribe-manufacturing-inc/84f6c422-aa60-4107-8244-d1365b7e617a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c